GlobeImmune offers little promise for IPO investors. Kris Tuttle 25 Sep 2012 Share on Twitter Share on Facebook Share on LinkedIn Share on Pinterest Share via Email Copy link This post is for paying subscribers only Subscribe Already have an account? Log in